Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes

Journal of Experimental Medicine

Volumn 192, Issue 5, 2000, Pages 613-623

  Kraft, Jennifer R ^a   Vance, Russell E ^b   Pohl, Jan ^a   Martin, Amy M ^a   Raulet, David H ^b   Jensen, Peter E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD94; Major histocompatibility complex; Natural killer cell; NKG2A; Qa 1

Indexed keywords

CD94 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; FLOW CYTOMETRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; BINDING SITES; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PROTEIN SORTING SIGNALS; RECEPTORS, IMMUNOLOGIC;

EID: 0034605035     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.5.613     Document Type: Article

References (60)

1. A new serologicaHy defined locus, Qa-1, in the Tla-region of the mouse
2. Expression of class I genes in the major histocompatibility complex: Identification of eight distinct mRNAs in DBA/2 mouse liver
3. A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types
4. The TL region gene 37 encodes a Qa-1 antigen
5. Unrestricted killer cells recognize an antigen controlled by a gene linked to Tla
6. H-2-nonrestricted cytotoxic responses to an antigen encoded telomeric to H-2D
7. Evidence for antigen presentation by the class Ib molecule, Qa-1
8. Structural and functional characteristics of the class IB molecule, Qa-1
9. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm
10. b antigens on cells lacking a functional Tap-2 transporter
11. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
12. b
13. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide
14. Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma
15. Heat shock proteins can regulate expression of the Tla region-encoded class Ib molecule Qa-1
16. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules
17. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens
18. b as a key restricting element for Listeria-specific CTLs
19. Response to Listeria monocytogenes in mice lacking MHC class la molecules
20. b
21. + T cells expressing V beta 8 TCR: A role of the Qa-1 molecule
22. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells
23. b
24. b molecule binds to a large subpopulation of murine NK cells
25. b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells
26. b-binding receptors in the specificity of developing NK cells
27. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
28. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A
29. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
30. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
31. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
32. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
33. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
34. Association of DAP12 with activating CD94/NKG2C NK cell receptors
35. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
36. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
37. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2 -A and the activating receptor CD94/NK G2-C to HLA-E
38. Phenotypic analysis of antigen-specific T lymphocytes
39. Peptide-binding specificity of the molecular chaperone BiP
40. Synthetic peptide libraries
41. A europium fluoroimmunoassay for measuring peptide binding to MHC class I molecules
42. Sequence analysis of peptide resins from Boc/benzyl solid-phase synthesis
43. b
44. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E
45. Allele-specific motifs revealed by sequencing of self -peptides eluted from MHC molecules
46. HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides
47. Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries
48. MHC ligands and peptide motifs: First listing
49. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice
50. - cells: A possible mechanism of tolerance during NK cell development
51. + T cells and natural killer cells
52. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
53. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells
54. Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C
55. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers
56. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
57. Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation
58. Viral strategies of immune evasion
59. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
60. Sequence of mouse hepatitis virus A59 mRNA 2: Indications for RNA recombination between coronaviruses and influenza C virus